A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.

P, Luo; P, Yin; R, Hua; Y, Tan; Z, Li; G, Qiu; Z, Yin; X, Xie; X, Wang; W, Chen; L, Zhou; X, Wang; Y, Li; H, Chen; L, Gao; X, Lu; T, Wu; H, Wang; J, Niu; G, Xu

doi:10.1002/hep.29561

Public

A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.

Shared by NobleBlocks on Jan 2, 2018 • 12:00 AM UTC

Authors:

Luo P

Yin P

Hua R

Abstract

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide. The lack of effective biomarkers for the early detection of HCC results in unsatisfactory curative treatments. Here, metabolite biomarkers were identified and validated for HCC diagnosis. A total of 1,448 subjects, including h...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!